Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Mirabel

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|September 13, 2006
Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trialP Michel, A Adenis, F Di Fiore, et al.
Annales De Dermatologie Et De Venereologie|August 17, 2016
[Update to the recommendations for management of melanoma stages I to III]B Guillot, S Dalac, M G Denis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2017
French updated recommendations in Stage I to III melanoma treatment and managementB Guillot, S Dalac, M G Denis, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 24, 2016
Clinical implementation of a Monte Carlo based treatment plan QA platform for validation of Cyberknife and Tomotherapy treatmentsN Reynaert, B Demol, M Charoy, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2007
[CyberKnife robotic stereotactic radiotherapy: technical aspects and medical indications]P-Y Bondiau, K Bénézery, V Beckendorf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative studyD Peiffert, J F Seitz, P Rougier, et al.
Dermatology (Basel, Switzerland)|December 24, 2009
Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativaC Lavogiez, E Delaporte, S Darras-Vercambre, et al.
Neuro-Chirurgie|September 22, 2014
[Locoregional treatments of brain metastases for patients with metastatic cutaneous melanoma: French national guidelines]V Lubrano, S Derrey, G Truc, et al.
Annales De Dermatologie Et De Venereologie|February 11, 2014
[Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute]M-T Leccia, F Planchamp, B Sassolas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancerD Azria, J Doyen, M Jarlier, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|September 13, 2006
Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trialP Michel, A Adenis, F Di Fiore, et al.
Annales De Dermatologie Et De Venereologie|August 17, 2016
[Update to the recommendations for management of melanoma stages I to III]B Guillot, S Dalac, M G Denis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2017
French updated recommendations in Stage I to III melanoma treatment and managementB Guillot, S Dalac, M G Denis, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 24, 2016
Clinical implementation of a Monte Carlo based treatment plan QA platform for validation of Cyberknife and Tomotherapy treatmentsN Reynaert, B Demol, M Charoy, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2007
[CyberKnife robotic stereotactic radiotherapy: technical aspects and medical indications]P-Y Bondiau, K Bénézery, V Beckendorf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative studyD Peiffert, J F Seitz, P Rougier, et al.
Dermatology (Basel, Switzerland)|December 24, 2009
Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativaC Lavogiez, E Delaporte, S Darras-Vercambre, et al.
Neuro-Chirurgie|September 22, 2014
[Locoregional treatments of brain metastases for patients with metastatic cutaneous melanoma: French national guidelines]V Lubrano, S Derrey, G Truc, et al.
Annales De Dermatologie Et De Venereologie|February 11, 2014
[Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute]M-T Leccia, F Planchamp, B Sassolas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancerD Azria, J Doyen, M Jarlier, et al.
Pageof 7